Bria, J.; Filardo, A.; Di Vito, A.; Della Torre, A.; Lavano, A.; Coscarella, I.; Chiarella, E.; Procopio, E.; Egiziano, M.T.; Longo, P.;
et al. Recurrent Limitations of CAR-T Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical Studies. Int. J. Mol. Sci. 2025, 26, 11435.
https://doi.org/10.3390/ijms262311435
AMA Style
Bria J, Filardo A, Di Vito A, Della Torre A, Lavano A, Coscarella I, Chiarella E, Procopio E, Egiziano MT, Longo P,
et al. Recurrent Limitations of CAR-T Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical Studies. International Journal of Molecular Sciences. 2025; 26(23):11435.
https://doi.org/10.3390/ijms262311435
Chicago/Turabian Style
Bria, Jessica, Andrea Filardo, Anna Di Vito, Attilio Della Torre, Angelo Lavano, Isabella Coscarella, Emanuela Chiarella, Emanuela Procopio, Maria Teresa Egiziano, Prospero Longo,
and et al. 2025. "Recurrent Limitations of CAR-T Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical Studies" International Journal of Molecular Sciences 26, no. 23: 11435.
https://doi.org/10.3390/ijms262311435
APA Style
Bria, J., Filardo, A., Di Vito, A., Della Torre, A., Lavano, A., Coscarella, I., Chiarella, E., Procopio, E., Egiziano, M. T., Longo, P., & La Torre, D.
(2025). Recurrent Limitations of CAR-T Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical Studies. International Journal of Molecular Sciences, 26(23), 11435.
https://doi.org/10.3390/ijms262311435
